Follow the people · Insider
GV 2019 GP, L.L.C.
GV 2019 GP, L.L.C. files insider transactions with the SEC as a 10% owner of Ethos Technologies (LIFE). We hold 12 disclosed purchases and sales filed since 17 February 2021, 10 of them in the last 90 days.
- Files forLIFE
- Disclosed buys and sells12 in all, 10 in the last 90 days
- Last disclosure29 July 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 14 May 2026 — 28 July 202610% owner · Ethos Technologies (LIFE)27 Form 4 lines · source: SEC Form 4
- Filed 12 May 2023 — 12 June 202310% owner · Prime Medicine (PRME)10 Form 4 lines · source: SEC Form 4
- Filed 17 February 2021 — 17 February 202110% owner · Decibel Therapeutics (DBTX)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
39 entries, newest first — one per disclosure report, one per Form 4 line- acquired or disposed of, other 196,931 shares of Ethos TechnologiesSEC Form 429 July 2026Class A Common Stock · traded 27 July 2026 · filed 29 July 2026
- ▼ sold on the open market 196,931 shares of Ethos TechnologiesSEC Form 429 July 2026Class A Common Stock · traded 27 July 2026 · filed 29 July 2026
- acquired or disposed of, other 118,138 shares of Ethos TechnologiesSEC Form 429 July 2026Class A Common Stock · traded 28 July 2026 · filed 29 July 2026
- ▼ sold on the open market 118,138 shares of Ethos TechnologiesSEC Form 429 July 2026Class A Common Stock · traded 28 July 2026 · filed 29 July 2026
- acquired or disposed of, other 63,297 shares of Ethos TechnologiesSEC Form 427 July 2026Class A Common Stock · traded 23 July 2026 · filed 27 July 2026
- ▼ sold on the open market 63,297 shares of Ethos TechnologiesSEC Form 427 July 2026Class A Common Stock · traded 23 July 2026 · filed 27 July 2026
- acquired or disposed of, other 23,417 shares of Ethos TechnologiesSEC Form 427 July 2026Class A Common Stock · traded 24 July 2026 · filed 27 July 2026
- ▼ sold on the open market 23,417 shares of Ethos TechnologiesSEC Form 427 July 2026Class A Common Stock · traded 24 July 2026 · filed 27 July 2026
- acquired or disposed of, other 22,900 shares of Ethos TechnologiesSEC Form 423 July 2026Class A Common Stock · traded 21 July 2026 · filed 23 July 2026
- ▼ sold on the open market 22,700 shares of Ethos TechnologiesSEC Form 423 July 2026Class A Common Stock · traded 21 July 2026 · filed 23 July 2026
- ▼ sold on the open market 200 shares of Ethos TechnologiesSEC Form 423 July 2026Class A Common Stock · traded 21 July 2026 · filed 23 July 2026
- acquired or disposed of, other 49,582 shares of Ethos TechnologiesSEC Form 423 July 2026Class A Common Stock · traded 22 July 2026 · filed 23 July 2026
- ▼ sold on the open market 49,582 shares of Ethos TechnologiesSEC Form 423 July 2026Class A Common Stock · traded 22 July 2026 · filed 23 July 2026
- acquired or disposed of, other 20,534 shares of Ethos TechnologiesSEC Form 421 July 2026Class A Common Stock · traded 17 July 2026 · filed 21 July 2026
- ▼ sold on the open market 20,534 shares of Ethos TechnologiesSEC Form 421 July 2026Class A Common Stock · traded 17 July 2026 · filed 21 July 2026
- acquired or disposed of, other 18,386 shares of Ethos TechnologiesSEC Form 421 July 2026Class A Common Stock · traded 20 July 2026 · filed 21 July 2026
- ▼ sold on the open market 18,386 shares of Ethos TechnologiesSEC Form 421 July 2026Class A Common Stock · traded 20 July 2026 · filed 21 July 2026
- acquired or disposed of, other 74,492 shares of Ethos TechnologiesSEC Form 417 July 2026Class A Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 12,500 shares of Ethos TechnologiesSEC Form 417 July 2026Class A Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 61,992 shares of Ethos TechnologiesSEC Form 417 July 2026Class A Common Stock · traded 15 July 2026 · filed 17 July 2026
- acquired or disposed of, other 19,595 shares of Ethos TechnologiesSEC Form 417 July 2026Class A Common Stock · traded 16 July 2026 · filed 17 July 2026
- ▼ sold on the open market 19,595 shares of Ethos TechnologiesSEC Form 417 July 2026Class A Common Stock · traded 16 July 2026 · filed 17 July 2026
- acquired or disposed of, other 60,077 shares of Ethos TechnologiesSEC Form 418 May 2026Class A Common Stock · traded 14 May 2026 · filed 18 May 2026
- ▼ sold on the open market 60,077 shares of Ethos TechnologiesSEC Form 418 May 2026Class A Common Stock · traded 14 May 2026 · filed 18 May 2026
- acquired or disposed of, other 87,475 shares of Ethos TechnologiesSEC Form 418 May 2026Class A Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 45,410 shares of Ethos TechnologiesSEC Form 418 May 2026Class A Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 42,065 shares of Ethos TechnologiesSEC Form 418 May 2026Class A Common Stock · traded 15 May 2026 · filed 18 May 2026
- acquired or disposed of, other 15,672 shares of Prime MedicineSEC Form 413 June 2023Common Stock · traded 9 June 2023 · filed 13 June 2023
- ▼ sold on the open market 15,672 shares of Prime MedicineSEC Form 413 June 2023Common Stock · traded 9 June 2023 · filed 13 June 2023
- acquired or disposed of, other 16,031 shares of Prime MedicineSEC Form 413 June 2023Common Stock · traded 12 June 2023 · filed 13 June 2023
- ▼ sold on the open market 16,031 shares of Prime MedicineSEC Form 413 June 2023Common Stock · traded 12 June 2023 · filed 13 June 2023
- acquired or disposed of, other 12,602 shares of Prime MedicineSEC Form 431 May 2023Common Stock · traded 26 May 2023 · filed 31 May 2023
- ▼ sold on the open market 12,602 shares of Prime MedicineSEC Form 431 May 2023Common Stock · traded 26 May 2023 · filed 31 May 2023
- acquired or disposed of, other 16,805 shares of Prime MedicineSEC Form 431 May 2023Common Stock · traded 30 May 2023 · filed 31 May 2023
- ▼ sold on the open market 16,805 shares of Prime MedicineSEC Form 431 May 2023Common Stock · traded 30 May 2023 · filed 31 May 2023
- ▼ sold on the open market 27,290 shares of Prime MedicineSEC Form 416 May 2023Common Stock · traded 12 May 2023 · filed 16 May 2023
- ▼ sold on the open market 157,952 shares of Prime MedicineSEC Form 416 May 2023Common Stock · traded 15 May 2023 · filed 16 May 2023
- converted 819,631 shares of Decibel TherapeuticsSEC Form 417 February 2021Common Stock · traded 17 February 2021 · filed 17 February 2021
- converted 4,344,048 shares of Decibel Therapeutics (a derivative holding)SEC Form 417 February 2021Series D Preferred Stock · traded 17 February 2021 · filed 17 February 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.